|1.||Kuehl, P J: 1 article (05/2007)|
|2.||Wightman, P D: 1 article (05/2007)|
|3.||Karlage, K: 1 article (05/2007)|
|4.||Angersbach, B S: 1 article (05/2007)|
|5.||Merrill, B A: 1 article (05/2007)|
|6.||Myrdal, P B: 1 article (05/2007)|
05/01/2007 - "The findings of this study offer compelling preliminary data for the use of S-29606 and S-30621 in further investigations of the treatment of pulmonary adenomas and support the use of inhalation drug delivery as an alternate to oral delivery for these compounds."
05/01/2007 - "Dose levels for S-29606 and S-30621 were determined to be 220 and 430 microg/kg for the low- and high-dose groups, respectively, whereas the dose of Zileuton was 245 mg/kg. Both test compounds exhibited a significant reduction of pulmonary adenomas, compared with a positive control for high and low doses, P < 0.05. "